Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study

All of RECERCAT

To access the full text documents, please follow this link: http://hdl.handle.net/2445/96104

dc.contributor	Universitat de Barcelona
dc.contributor.author	Gatell, José M.
dc.contributor.author	INSIGHT STALWART Study Group
dc.date	2016-03-03T15:19:05Z
dc.date	2016-03-03T15:19:05Z
dc.date	2010
dc.date	2016-03-03T15:19:10Z
dc.identifier.citation	1932-6203
dc.identifier.citation	610831
dc.identifier.uri	http://hdl.handle.net/2445/96104
dc.format	9 p.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	Public Library of Science (PLoS)
dc.relation	Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0009334
dc.relation	PLoS One, 2010, vol. 5, num. 2, p. e9334
dc.relation	http://dx.doi.org/10.1371/journal.pone.0009334
dc.rights	cc-by (c) Gatell, José M. et al., 2010
dc.rights	info:eu-repo/semantics/openAccess
dc.rights	http://creativecommons.org/licenses/by/3.0/es
dc.subject	Antiretrovirals
dc.subject	VIH (Virus)
dc.subject	Antiretroviral agents
dc.subject	HIV (Viruses)
dc.title	Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.abstract	The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4+ counts compared to no therapy.